Kyntra Bio, Inc. (KYNB)
9.22
-0.28
(-2.95%)
USD |
NASDAQ |
Jan 09, 16:00
9.41
+0.19
(+2.06%)
After-Hours: 20:00
Kyntra Bio Market Cap: 37.27M for Jan. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Assertio Holdings, Inc. | 58.97M |
| Perspective Therapeutics, Inc. | 211.12M |
| Skye Bioscience, Inc. | 31.42M |
| Theravance Biopharma, Inc. | 964.80M |
| Myomo, Inc. | 37.98M |
Market Cap Related Metrics
| PE Ratio | 0.2344 |
| PS Ratio | 31.41 |
| Price | 9.22 |
| Earnings Yield | 426.7% |
| Normalized PE Ratio | 0.2265 |